79 related articles for article (PubMed ID: 21826973)
21. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
Seyednejad N; Kuusk U; Wiseman SM
Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
[TBL] [Abstract][Full Text] [Related]
22. Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: With or without axillary lymph node dissection.
Chen JJ; Wu J
Crit Rev Oncol Hematol; 2011 Sep; 79(3):293-301. PubMed ID: 20663684
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
24. [Validation study of the sentinel lymph node (SLN) method in invasive breast carcinoma. Personal data and review of the literature].
Langer I; Zuber M; Köchli OR; Kocher T; Müller-Brand J; Torhorst J; Harder F
Swiss Surg; 2000; 6(3):128-36. PubMed ID: 10894014
[TBL] [Abstract][Full Text] [Related]
25. [Management of axillary and internal mammary lymph nodes in primary breast cancer].
Masuda N; Tamaki Y; Noguchi S
Nihon Geka Gakkai Zasshi; 2001 Jun; 102(6):465-72. PubMed ID: 11436509
[TBL] [Abstract][Full Text] [Related]
26. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
27. The need for lymph node dissection in nonmetastatic breast cancer.
Pesce C; Morrow M
Annu Rev Med; 2013; 64():119-29. PubMed ID: 23020881
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy. Preferred method of axillary staging for breast cancer.
Tuttle TM
Minerva Ginecol; 2005 Jun; 57(3):293-303. PubMed ID: 16166937
[TBL] [Abstract][Full Text] [Related]
29. Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond.
Gatzemeier W; Mann GB
Breast; 2013 Jun; 22(3):211-6. PubMed ID: 23478200
[TBL] [Abstract][Full Text] [Related]
30. Axillary surgery for breast cancer: past, present, and future.
Noguchi M; Inokuchi M; Noguchi M; Morioka E; Ohno Y; Kurita T
Breast Cancer; 2021 Jan; 28(1):9-15. PubMed ID: 33165758
[TBL] [Abstract][Full Text] [Related]
31. The benefits and limitations of sentinel lymph node biopsy.
Amersi F; Hansen NM
Curr Treat Options Oncol; 2006 Mar; 7(2):141-51. PubMed ID: 16455025
[TBL] [Abstract][Full Text] [Related]
32. Conservative axillary surgery is emerging in the surgical management of breast cancer.
Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E; Haba Y
Breast Cancer; 2023 Jan; 30(1):14-22. PubMed ID: 36342647
[TBL] [Abstract][Full Text] [Related]
33. Axillary reverse mapping (ARM): where to go.
Shao X; Sun B; Shen Y
Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: Work in progress.
Rubio IT
Eur J Surg Oncol; 2016 Mar; 42(3):326-32. PubMed ID: 26774943
[TBL] [Abstract][Full Text] [Related]
35. Will we need lymph node dissection at all in the future?
Bourez RL; Rutgers EJ; Van De Velde CJ
Clin Breast Cancer; 2002 Dec; 3(5):315-22; discussion 323-5. PubMed ID: 12533260
[TBL] [Abstract][Full Text] [Related]
36. Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.
Noguchi M; Inokuchi M; Noguchi M; Morioka E; Kurita T
Eur J Surg Oncol; 2020 Dec; 46(12):2218-2220. PubMed ID: 32912671
[TBL] [Abstract][Full Text] [Related]
37. The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future?
Lopez Penha TR; van Roozendaal LM; Smidt ML; Boersma LJ; von Meyenfeldt MF; Voogd AC; Heuts EM
Breast; 2015 Oct; 24(5):543-7. PubMed ID: 26051795
[TBL] [Abstract][Full Text] [Related]
38. Axillary node interventions in breast cancer: a systematic review.
Rao R; Euhus D; Mayo HG; Balch C
JAMA; 2013 Oct; 310(13):1385-94. PubMed ID: 24084924
[TBL] [Abstract][Full Text] [Related]
39. The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
Han C; Yang B; Zuo WS; Zheng G; Yang L; Zheng MZ
PLoS One; 2016; 11(2):e0150285. PubMed ID: 26919589
[TBL] [Abstract][Full Text] [Related]
40. Clinical and pathologic factors predicting axillary lymph node involvement in breast cancer.
Noguchi M; Kurosumi M; Iwata H; Miyauchi M; Ohta M; Imoto S; Motomura K; Sato K; Tsugawa K
Breast Cancer; 2000; 7(2):114-23. PubMed ID: 11029782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
